9.770
−0,31%
2026-10-19
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -75.8% | -46.2% | 1 / 3 | -4.2% | -2.46 pp | -8.23 pp | +4.7% | 0.21 | 12.72 | 610 | −4,2% | 17,7 | −75,0% | 12.72 | 9.83 | +29,4% |
| Pts | 0 | 0 | 4 | 0 | 4 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 9.770 (close price on 2026-10-19)EPS (TTM): 767,8
Financial charts
1.Revenue & growth
VND bn610Q2/26
1.Revenue & growth
VND bn610Q2/26
2.Profit & growth
VND bn17,7Q2/26
3.Profit mix (Penman)
VND bn130Q2/26
4.Margins & cost structure
%16.5%Q2/26
5.Returns & cash cycle
% · days5.7%Q2/26
6.Earnings quality & cash
VND bn21,6Q2/26
7.Asset structure
VND bn2.702Q2/26
8.Funding & debt health
VND bn · times2.702Q2/26
9.Revenue backlog
VND bn46,2Q2/26
10.Valuation
times · %12,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %157Q2/26
Adjusted EPS growth, latest quarter
-83.9%
Average adjusted EPS growth, 3 quarters
-48.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
55.0%
Source: vnstockData through Q2/26